News Biogen signs $1bn gene therapy deal; CF trial shows promise Biogen following move into regenerative medicine
Articles Market access for specialist medicines in the UK: the Price ... A recent pharmaphorum webinar brought four experts together to discuss the future of market access for specialist medicines in the UK.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
